1	Lipopolysaccharide	lipopolysaccharide	NN	NN	_	11	nsubj	_	_
2	from	from	IN	IN	_	1	prep	_	_
3	nonvirulent	nonvirulent	JJ	JJ	_	8	amod	_	_
4	Ara	Ara	NNP	NNP	_	8	nn	_	_
5	+	+	CC	CC	_	4	cc	_	_
6	Burkholderia	Burkholderia	NNP	NNP	_	4	conj	_	_
7	pseudomallei	pseudomallei	NN	NN	_	8	nn	_	_
8	isolates	isolate	NNS	NNS	_	2	pobj	_	_
9	is	be	VBZ	VBZ	_	11	cop	_	_
10	immunologically	immunologically	RB	RB	_	11	advmod	_	_
11	indistinguishable	indistinguishable	JJ	JJ	_	0	ROOT	_	_
12	from	from	IN	IN	_	11	prep	_	_
13	lipopolysaccharide	lipopolysaccharide	NN	NN	_	12	pobj	_	_
14	from	from	IN	IN	_	13	prep	_	_
15	virulent	virulent	JJ	JJ	_	16	amod	_	_
16	Ara	Ara	NNP	NNP	_	14	pobj	_	_
17	-	-	:	:	_	16	punct	_	_
18	clinical	clinical	JJ	JJ	_	19	amod	_	_
19	isolates	isolate	NNS	NNS	_	16	dep	_	_
20	.	.	.	.	_	11	punct	_	_

1	Different	different	JJ	JJ	_	2	amod	_	_
2	lines	line	NNS	NNS	_	5	nsubj	_	_
3	of	of	IN	IN	_	2	prep	_	_
4	evidence	evidence	NN	NN	_	3	pobj	_	_
5	suggest	suggest	VBP	VBP	_	0	ROOT	_	_
6	that	that	IN	IN	_	29	mark	_	_
7	a	a	DT	DT	_	8	det	_	_
8	discrepancy	discrepancy	NN	NN	_	29	nsubj	_	_
9	between	between	IN	IN	_	8	prep	_	_
10	the	the	DT	DT	_	11	det	_	_
11	distribution	distribution	NN	NN	_	9	pobj	_	_
12	of	of	IN	IN	_	11	prep	_	_
13	Burkholderia	Burkholderia	NNP	NNP	_	17	nn	_	_
14	-LRB-	-lrb-	-LRB-	-LRB-	_	15	punct	_	_
15	Pseudomonas	pseudomonas	FW	FW	_	13	appos	_	_
16	-RRB-	-rrb-	-RRB-	-RRB-	_	15	punct	_	_
17	pseudomallei	pseudomallei	NN	NN	_	12	pobj	_	_
18	in	in	IN	IN	_	11	prep	_	_
19	the	the	DT	DT	_	20	det	_	_
20	environment	environment	NN	NN	_	18	pobj	_	_
21	and	and	CC	CC	_	11	cc	_	_
22	the	the	DT	DT	_	23	det	_	_
23	distribution	distribution	NN	NN	_	11	conj	_	_
24	of	of	IN	IN	_	23	prep	_	_
25	the	the	DT	DT	_	27	det	_	_
26	disease	disease	NN	NN	_	27	nn	_	_
27	melioidosis	melioidosis	NN	NN	_	24	pobj	_	_
28	is	be	VBZ	VBZ	_	29	cop	_	_
29	attributable	attributable	JJ	JJ	_	5	ccomp	_	_
30	,	,	,	,	_	29	punct	_	_
31	at	at	IN	IN	_	33	advmod	_	_
32	least	least	JJS	JJS	_	31	pobj	_	_
33	in	in	IN	IN	_	29	prep	_	_
34	part	part	NN	NN	_	33	pobj	_	_
35	,	,	,	,	_	29	punct	_	_
36	to	to	TO	TO	_	29	prep	_	_
37	phenotypic	phenotypic	JJ	JJ	_	38	amod	_	_
38	differences	difference	NNS	NNS	_	36	pobj	_	_
39	between	between	IN	IN	_	38	prep	_	_
40	clinical	clinical	JJ	JJ	_	39	pobj	_	_
41	and	and	CC	CC	_	40	cc	_	_
42	some	some	DT	DT	_	44	det	_	_
43	environmental	environmental	JJ	JJ	_	44	amod	_	_
44	isolates	isolate	NNS	NNS	_	40	conj	_	_
45	.	.	.	.	_	5	punct	_	_

1	Two	two	CD	CD	_	6	num	_	_
2	antigenically	antigenically	RB	RB	_	5	advmod	_	_
3	and	and	CC	CC	_	2	cc	_	_
4	biochemically	biochemically	RB	RB	_	2	conj	_	_
5	distinct	distinct	JJ	JJ	_	6	amod	_	_
6	biotypes	biotype	NNS	NNS	_	9	nsubjpass	_	_
7	have	have	VBP	VBP	_	9	aux	_	_
8	been	be	VBN	VBN	_	9	auxpass	_	_
9	described	describe	VBN	VBN	_	0	ROOT	_	_
10	,	,	,	,	_	9	punct	_	_
11	only	only	RB	RB	_	12	advmod	_	_
12	one	one	CD	CD	_	16	nsubj	_	_
13	of	of	IN	IN	_	12	prep	_	_
14	which	which	WDT	WDT	_	13	pobj	_	_
15	is	be	VBZ	VBZ	_	16	cop	_	_
16	virulent	virulent	JJ	JJ	_	9	ccomp	_	_
17	.	.	.	.	_	9	punct	_	_

1	In	in	IN	IN	_	10	prep	_	_
2	this	this	DT	DT	_	3	det	_	_
3	study	study	NN	NN	_	1	pobj	_	_
4	,	,	,	,	_	10	punct	_	_
5	lipopolysaccharides	lipopolysaccharide	NNS	NNS	_	10	nsubjpass	_	_
6	-LRB-	-lrb-	-LRB-	-LRB-	_	7	punct	_	_
7	LPSs	lpss	NNS	NNS	_	5	appos	_	_
8	-RRB-	-rrb-	-RRB-	-RRB-	_	7	punct	_	_
9	were	be	VBD	VBD	_	10	auxpass	_	_
10	extracted	extract	VBN	VBN	_	0	ROOT	_	_
11	by	by	IN	IN	_	10	prep	_	_
12	the	the	DT	DT	_	16	det	_	_
13	proteinase	proteinase	NN	NN	_	16	nn	_	_
14	K	k	NN	NN	_	16	nn	_	_
15	digestion	digestion	NN	NN	_	16	nn	_	_
16	method	method	NN	NN	_	11	pobj	_	_
17	from	from	IN	IN	_	16	prep	_	_
18	a	a	DT	DT	_	19	det	_	_
19	total	total	NN	NN	_	17	pobj	_	_
20	of	of	IN	IN	_	19	prep	_	_
21	214	214	CD	CD	_	24	num	_	_
22	B.	B.	NNP	NNP	_	24	nn	_	_
23	pseudomallei	pseudomallei	NN	NN	_	24	nn	_	_
24	isolates	isolate	NNS	NNS	_	20	pobj	_	_
25	,	,	,	,	_	10	punct	_	_
26	and	and	CC	CC	_	10	cc	_	_
27	their	they	PRP$	PRP$	_	28	poss	_	_
28	immunoreactivities	immunoreactivity	NNS	NNS	_	42	nsubjpass	_	_
29	with	with	IN	IN	_	28	prep	_	_
30	sera	serum	NNS	NNS	_	29	pobj	_	_
31	from	from	IN	IN	_	30	prep	_	_
32	patients	patient	NNS	NNS	_	31	pobj	_	_
33	with	with	IN	IN	_	32	prep	_	_
34	different	different	JJ	JJ	_	36	amod	_	_
35	clinical	clinical	JJ	JJ	_	36	amod	_	_
36	spectra	spectrum	NNS	NNS	_	33	pobj	_	_
37	and	and	CC	CC	_	28	cc	_	_
38	with	with	IN	IN	_	28	conj	_	_
39	other	other	JJ	JJ	_	40	amod	_	_
40	infections	infection	NNS	NNS	_	38	pobj	_	_
41	were	be	VBD	VBD	_	42	auxpass	_	_
42	evaluated	evaluate	VBN	VBN	_	10	conj	_	_
43	.	.	.	.	_	10	punct	_	_

1	With	with	IN	IN	_	5	mark	_	_
2	the	the	DT	DT	_	3	det	_	_
3	exception	exception	NN	NN	_	5	nsubj	_	_
4	of4	of4	NN	NN	_	5	nn	_	_
5	isolates	isolate	NNS	NNS	_	28	advcl	_	_
6	from	from	IN	IN	_	5	prep	_	_
7	a	a	DT	DT	_	8	det	_	_
8	total	total	NN	NN	_	6	pobj	_	_
9	of	of	IN	IN	_	8	prep	_	_
10	214	214	CD	CD	_	9	pobj	_	_
11	tested	test	VBN	VBN	_	10	vmod	_	_
12	,	,	,	,	_	28	punct	_	_
13	the	the	DT	DT	_	20	det	_	_
14	sodium	sodium	NN	NN	_	20	nn	_	_
15	dodecyl	dodecyl	NN	NN	_	20	nn	_	_
16	sulfate-polyacrylamide	sulfate-polyacrylamide	JJ	JJ	_	20	amod	_	_
17	gel	gel	NN	NN	_	20	nn	_	_
18	electrophoresis	electrophoresis	NN	NN	_	20	nn	_	_
19	silver-staining	silver-staining	JJ	JJ	_	20	amod	_	_
20	profiles	profile	NNS	NNS	_	28	nsubj	_	_
21	of	of	IN	IN	_	20	prep	_	_
22	the	the	DT	DT	_	23	det	_	_
23	LPSs	lpss	NNS	NNS	_	21	pobj	_	_
24	from	from	IN	IN	_	20	prep	_	_
25	the	the	DT	DT	_	27	det	_	_
26	two	two	CD	CD	_	27	num	_	_
27	biotypes	biotype	NNS	NNS	_	24	pobj	_	_
28	showed	show	VBD	VBD	_	0	ROOT	_	_
29	identical	identical	JJ	JJ	_	31	amod	_	_
30	ladder	ladder	NN	NN	_	31	nn	_	_
31	patterns	pattern	NNS	NNS	_	28	dobj	_	_
32	that	that	WDT	WDT	_	34	nsubj	_	_
33	were	be	VBD	VBD	_	34	cop	_	_
34	typical	typical	JJ	JJ	_	31	rcmod	_	_
35	for	for	IN	IN	_	34	prep	_	_
36	smooth	smooth	JJ	JJ	_	37	amod	_	_
37	LPSs	lpss	NNS	NNS	_	35	pobj	_	_
38	from	from	IN	IN	_	37	prep	_	_
39	other	other	JJ	JJ	_	41	amod	_	_
40	gram-negative	gram-negative	JJ	JJ	_	41	amod	_	_
41	bacteria	bacterium	NNS	NNS	_	38	pobj	_	_
42	.	.	.	.	_	28	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	210	210	CD	CD	_	3	num	_	_
3	isolates	isolate	NNS	NNS	_	34	nsubj	_	_
4	with	with	IN	IN	_	3	prep	_	_
5	typical	typical	JJ	JJ	_	7	amod	_	_
6	LPS	lps	NN	NN	_	7	nn	_	_
7	patterns	pattern	NNS	NNS	_	4	pobj	_	_
8	-LRB-	-lrb-	-LRB-	-LRB-	_	10	punct	_	_
9	119	119	CD	CD	_	10	num	_	_
10	Ara	Ara	NNP	NNP	_	7	dep	_	_
11	-	-	:	:	_	10	punct	_	_
12	clinical	clinical	JJ	JJ	_	10	dep	_	_
13	,	,	,	,	_	10	punct	_	_
14	13	13	CD	CD	_	15	num	_	_
15	Ara	Ara	NNP	NNP	_	10	dep	_	_
16	-	-	:	:	_	10	punct	_	_
17	soil	soil	NN	NN	_	10	dep	_	_
18	,	,	,	,	_	10	punct	_	_
19	70	70	CD	CD	_	20	num	_	_
20	Ara	Ara	NNP	NNP	_	10	appos	_	_
21	+	+	CC	CC	_	20	cc	_	_
22	soil	soil	NN	NN	_	20	conj	_	_
23	,	,	,	,	_	10	punct	_	_
24	and	and	CC	CC	_	10	cc	_	_
25	8	8	CD	CD	_	31	num	_	_
26	reference	reference	NN	NN	_	31	nn	_	_
27	National	National	NNP	NNP	_	31	nn	_	_
28	Type	type	NN	NN	_	31	nn	_	_
29	Culture	culture	NN	NN	_	31	nn	_	_
30	Collection	collection	NN	NN	_	31	nn	_	_
31	strains	strain	NNS	NNS	_	10	conj	_	_
32	-RRB-	-rrb-	-RRB-	-RRB-	_	10	punct	_	_
33	also	also	RB	RB	_	34	advmod	_	_
34	exhibited	exhibit	VBD	VBD	_	0	ROOT	_	_
35	similar	similar	JJ	JJ	_	37	amod	_	_
36	immunoblot	immunoblot	NN	NN	_	37	nn	_	_
37	profiles	profile	NNS	NNS	_	34	dobj	_	_
38	against	against	IN	IN	_	37	prep	_	_
39	pooled	pool	VBN	VBN	_	40	amod	_	_
40	sera	serum	NNS	NNS	_	38	pobj	_	_
41	from	from	IN	IN	_	40	prep	_	_
42	patients	patient	NNS	NNS	_	41	pobj	_	_
43	with	with	IN	IN	_	42	prep	_	_
44	melioidosis	melioidosis	NN	NN	_	43	pobj	_	_
45	and	and	CC	CC	_	44	cc	_	_
46	hyperimmune	hyperimmune	NN	NN	_	48	nn	_	_
47	mouse	mouse	NN	NN	_	48	nn	_	_
48	sera	sera	NN	NN	_	44	conj	_	_
49	.	.	.	.	_	34	punct	_	_

1	Concordant	concordant	JJ	JJ	_	2	amod	_	_
2	findings	finding	NNS	NNS	_	4	nsubjpass	_	_
3	were	be	VBD	VBD	_	4	auxpass	_	_
4	noted	note	VBN	VBN	_	0	ROOT	_	_
5	in	in	IN	IN	_	4	prep	_	_
6	the	the	DT	DT	_	10	det	_	_
7	indirect	indirect	JJ	JJ	_	10	amod	_	_
8	enzyme-linked	enzyme-linked	JJ	JJ	_	10	amod	_	_
9	immunosorbent	immunosorbent	JJ	JJ	_	10	amod	_	_
10	assay	assay	NN	NN	_	5	pobj	_	_
11	with	with	IN	IN	_	10	prep	_	_
12	Ara	Ara	NNP	NNP	_	11	pobj	_	_
13	-	-	:	:	_	4	punct	_	_
14	and	and	CC	CC	_	4	cc	_	_
15	Ara	Ara	NNP	NNP	_	19	nn	_	_
16	+	+	CC	CC	_	15	cc	_	_
17	LPSs	lpss	NNS	NNS	_	15	conj	_	_
18	to	to	TO	TO	_	19	aux	_	_
19	coat	coat	NN	NN	_	4	conj	_	_
20	the	the	DT	DT	_	22	det	_	_
21	microtiter	microtiter	NN	NN	_	22	nn	_	_
22	plates	plate	NNS	NNS	_	19	dep	_	_
23	.	.	.	.	_	4	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	LPSs	lpss	NNS	NNS	_	9	nsubj	_	_
3	of	of	IN	IN	_	2	prep	_	_
4	the	the	DT	DT	_	8	det	_	_
5	different	different	JJ	JJ	_	8	amod	_	_
6	B.	B.	NNP	NNP	_	8	nn	_	_
7	pseudomallei	pseudomallei	NN	NN	_	8	nn	_	_
8	biotypes	biotype	NNS	NNS	_	3	pobj	_	_
9	appear	appear	VBP	VBP	_	0	ROOT	_	_
10	antigenically	antigenically	RB	RB	_	11	advmod	_	_
11	indistinguishable	indistinguishable	JJ	JJ	_	9	acomp	_	_
12	.	.	.	.	_	9	punct	_	_

1	It	it	PRP	PRP	_	0	ROOT	_	_
2	is	be	VBZ	VBZ	_	1	dep	_	_
3	,	,	,	,	_	4	punct	_	_
4	therefore	therefore	RB	RB	_	2	dep	_	_
5	,	,	,	,	_	6	punct	_	_
6	unlikely	unlikely	JJ	JJ	_	4	dep	_	_
7	that	that	IN	IN	_	11	mark	_	_
8	this	this	DT	DT	_	9	det	_	_
9	component	component	NN	NN	_	11	nsubjpass	_	_
10	is	be	VBZ	VBZ	_	11	auxpass	_	_
11	related	relate	VBN	VBN	_	6	ccomp	_	_
12	to	to	TO	TO	_	11	prep	_	_
13	the	the	DT	DT	_	14	det	_	_
14	virulence	virulence	NN	NN	_	12	pobj	_	_
15	and	and	CC	CC	_	14	cc	_	_
16	pathogenicity	pathogenicity	NN	NN	_	14	conj	_	_
17	of	of	IN	IN	_	14	prep	_	_
18	B.	B.	NNP	NNP	_	19	nn	_	_
19	pseudomallei	pseudomallei	NNP	NNP	_	17	pobj	_	_
20	.	.	.	.	_	6	punct	_	_
